[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Antihypertensive Drugs Sales Market Report 2016

December 2016 | 112 pages | ID: G6BCAA3465AEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Antihypertensive Drugs

Revenue, means the sales value of Antihypertensive Drugs

This report studies sales (consumption) of Antihypertensive Drugs in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
  • Novartis AG
  • Pfizer, Inc.
  • Johnson & Johnson Ltd.
  • Sanofi S.A.
  • Lupin Limited
  • Ranbaxy Laboratories Limited
  • Merck & Co., Inc.
  • Astra Zeneca Plc
  • Daiichi Sankyo Company Limited
  • Takeda Pharmaceutical Company Limited
  • Actelion Ltd.
  • United Therapeutics Corp
Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Antihypertensive Drugs in these regions, from 2011 to 2021 (forecast), like
  • United States
  • China
  • Europe
  • Japan
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
  • ARB
  • CCB
  • Other
Split by applications, this report focuses on sales, market share and growth rate of Antihypertensive Drugs in each application, can be divided into
  • Hypertension
  • PAH
  • Other
Global Antihypertensive Drugs Sales Market Report 2016

1 ANTIHYPERTENSIVE DRUGS OVERVIEW

1.1 Product Overview and Scope of Antihypertensive Drugs
1.2 Classification of Antihypertensive Drugs
  1.2.1 ARB
  1.2.2 CCB
  1.2.3 Other
1.3 Application of Antihypertensive Drugs
  1.3.1 Hypertension
  1.3.2 PAH
  1.3.3 Other
1.4 Antihypertensive Drugs Market by Regions
  1.4.1 United States Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Antihypertensive Drugs (2011-2021)
  1.5.1 Global Antihypertensive Drugs Sales and Growth Rate (2011-2021)
  1.5.2 Global Antihypertensive Drugs Revenue and Growth Rate (2011-2021)

2 GLOBAL ANTIHYPERTENSIVE DRUGS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Antihypertensive Drugs Market Competition by Manufacturers
  2.1.1 Global Antihypertensive Drugs Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Antihypertensive Drugs Revenue and Share by Manufacturers (2011-2016)
2.2 Global Antihypertensive Drugs (Volume and Value) by Type
  2.2.1 Global Antihypertensive Drugs Sales and Market Share by Type (2011-2016)
  2.2.2 Global Antihypertensive Drugs Revenue and Market Share by Type (2011-2016)
2.3 Global Antihypertensive Drugs (Volume and Value) by Regions
  2.3.1 Global Antihypertensive Drugs Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Antihypertensive Drugs Revenue and Market Share by Regions (2011-2016)
2.4 Global Antihypertensive Drugs (Volume) by Application

3 UNITED STATES ANTIHYPERTENSIVE DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Antihypertensive Drugs Sales and Value (2011-2016)
  3.1.1 United States Antihypertensive Drugs Sales and Growth Rate (2011-2016)
  3.1.2 United States Antihypertensive Drugs Revenue and Growth Rate (2011-2016)
  3.1.3 United States Antihypertensive Drugs Sales Price Trend (2011-2016)
3.2 United States Antihypertensive Drugs Sales and Market Share by Manufacturers
3.3 United States Antihypertensive Drugs Sales and Market Share by Type
3.4 United States Antihypertensive Drugs Sales and Market Share by Application

4 CHINA ANTIHYPERTENSIVE DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 China Antihypertensive Drugs Sales and Value (2011-2016)
  4.1.1 China Antihypertensive Drugs Sales and Growth Rate (2011-2016)
  4.1.2 China Antihypertensive Drugs Revenue and Growth Rate (2011-2016)
  4.1.3 China Antihypertensive Drugs Sales Price Trend (2011-2016)
4.2 China Antihypertensive Drugs Sales and Market Share by Manufacturers
4.3 China Antihypertensive Drugs Sales and Market Share by Type
4.4 China Antihypertensive Drugs Sales and Market Share by Application

5 EUROPE ANTIHYPERTENSIVE DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Antihypertensive Drugs Sales and Value (2011-2016)
  5.1.1 Europe Antihypertensive Drugs Sales and Growth Rate (2011-2016)
  5.1.2 Europe Antihypertensive Drugs Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Antihypertensive Drugs Sales Price Trend (2011-2016)
5.2 Europe Antihypertensive Drugs Sales and Market Share by Manufacturers
5.3 Europe Antihypertensive Drugs Sales and Market Share by Type
5.4 Europe Antihypertensive Drugs Sales and Market Share by Application

6 JAPAN ANTIHYPERTENSIVE DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Antihypertensive Drugs Sales and Value (2011-2016)
  6.1.1 Japan Antihypertensive Drugs Sales and Growth Rate (2011-2016)
  6.1.2 Japan Antihypertensive Drugs Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Antihypertensive Drugs Sales Price Trend (2011-2016)
6.2 Japan Antihypertensive Drugs Sales and Market Share by Manufacturers
6.3 Japan Antihypertensive Drugs Sales and Market Share by Type
6.4 Japan Antihypertensive Drugs Sales and Market Share by Application

7 GLOBAL ANTIHYPERTENSIVE DRUGS MANUFACTURERS ANALYSIS

7.1 Novartis AG
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Antihypertensive Drugs Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Novartis AG Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.1.4 Main Business/Business Overview
7.2 Pfizer, Inc.
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 112 Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Pfizer, Inc. Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.2.4 Main Business/Business Overview
7.3 Johnson & Johnson Ltd.
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 131 Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Johnson & Johnson Ltd. Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.3.4 Main Business/Business Overview
7.4 Sanofi S.A.
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Dec Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Sanofi S.A. Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.4.4 Main Business/Business Overview
7.5 Lupin Limited
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Lupin Limited Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.5.4 Main Business/Business Overview
7.6 Ranbaxy Laboratories Limited
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Million USD Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Ranbaxy Laboratories Limited Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.6.4 Main Business/Business Overview
7.7 Merck & Co., Inc.
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Pharmaceuticals Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Merck & Co., Inc. Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.7.4 Main Business/Business Overview
7.8 Astra Zeneca Plc
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Astra Zeneca Plc Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.8.4 Main Business/Business Overview
7.9 Daiichi Sankyo Company Limited
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Daiichi Sankyo Company Limited Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.9.4 Main Business/Business Overview
7.10 Takeda Pharmaceutical Company Limited
  7.10.1 Company Basic Information, Manufacturing Base and Competitors
  7.10.2 Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Takeda Pharmaceutical Company Limited Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  7.10.4 Main Business/Business Overview
7.11 Actelion Ltd.
7.12 United Therapeutics Corp

8 ANTIHYPERTENSIVE DRUGS MAUFACTURING COST ANALYSIS

8.1 Antihypertensive Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Process Analysis of Antihypertensive Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Antihypertensive Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Antihypertensive Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL ANTIHYPERTENSIVE DRUGS MARKET FORECAST (2016-2021)

12.1 Global Antihypertensive Drugs Sales, Revenue Forecast (2016-2021)
12.2 Global Antihypertensive Drugs Sales Forecast by Regions (2016-2021)
12.3 Global Antihypertensive Drugs Sales Forecast by Type (2016-2021)
12.4 Global Antihypertensive Drugs Sales Forecast by Application (2016-2021)

13 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Antihypertensive Drugs
Table Classification of Antihypertensive Drugs
Figure Global Sales Market Share of Antihypertensive Drugs by Type in 2015
Figure ARB Picture
Figure CCB Picture
Figure Other Picture
Table Applications of Antihypertensive Drugs
Figure Global Sales Market Share of Antihypertensive Drugs by Application in 2015
Figure Hypertension Examples
Figure PAH Examples
Figure Other Examples
Figure United States Antihypertensive Drugs Revenue and Growth Rate (2011-2021)
Figure China Antihypertensive Drugs Revenue and Growth Rate (2011-2021)
Figure Europe Antihypertensive Drugs Revenue and Growth Rate (2011-2021)
Figure Japan Antihypertensive Drugs Revenue and Growth Rate (2011-2021)
Figure Global Antihypertensive Drugs Sales and Growth Rate (2011-2021)
Figure Global Antihypertensive Drugs Revenue and Growth Rate (2011-2021)
Table Global Antihypertensive Drugs Sales of Key Manufacturers (2011-2016)
Table Global Antihypertensive Drugs Sales Share by Manufacturers (2011-2016)
Figure 2015 Antihypertensive Drugs Sales Share by Manufacturers
Figure 2016 Antihypertensive Drugs Sales Share by Manufacturers
Table Global Antihypertensive Drugs Revenue by Manufacturers (2011-2016)
Table Global Antihypertensive Drugs Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Antihypertensive Drugs Revenue Share by Manufacturers
Table 2016 Global Antihypertensive Drugs Revenue Share by Manufacturers
Table Global Antihypertensive Drugs Sales and Market Share by Type (2011-2016)
Table Global Antihypertensive Drugs Sales Share by Type (2011-2016)
Figure Sales Market Share of Antihypertensive Drugs by Type (2011-2016)
Figure Global Antihypertensive Drugs Sales Growth Rate by Type (2011-2016)
Table Global Antihypertensive Drugs Revenue and Market Share by Type (2011-2016)
Table Global Antihypertensive Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Antihypertensive Drugs by Type (2011-2016)
Figure Global Antihypertensive Drugs Revenue Growth Rate by Type (2011-2016)
Table Global Antihypertensive Drugs Sales and Market Share by Regions (2011-2016)
Table Global Antihypertensive Drugs Sales Share by Regions (2011-2016)
Figure Sales Market Share of Antihypertensive Drugs by Regions (2011-2016)
Figure Global Antihypertensive Drugs Sales Growth Rate by Regions (2011-2016)
Table Global Antihypertensive Drugs Revenue and Market Share by Regions (2011-2016)
Table Global Antihypertensive Drugs Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Antihypertensive Drugs by Regions (2011-2016)
Figure Global Antihypertensive Drugs Revenue Growth Rate by Regions (2011-2016)
Table Global Antihypertensive Drugs Sales and Market Share by Application (2011-2016)
Table Global Antihypertensive Drugs Sales Share by Application (2011-2016)
Figure Sales Market Share of Antihypertensive Drugs by Application (2011-2016)
Figure Global Antihypertensive Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Antihypertensive Drugs Sales and Growth Rate (2011-2016)
Figure United States Antihypertensive Drugs Revenue and Growth Rate (2011-2016)
Figure United States Antihypertensive Drugs Sales Price Trend (2011-2016)
Table United States Antihypertensive Drugs Sales by Manufacturers (2011-2016)
Table United States Antihypertensive Drugs Market Share by Manufacturers (2011-2016)
Table United States Antihypertensive Drugs Sales by Type (2011-2016)
Table United States Antihypertensive Drugs Market Share by Type (2011-2016)
Table United States Antihypertensive Drugs Sales by Application (2011-2016)
Table United States Antihypertensive Drugs Market Share by Application (2011-2016)
Figure China Antihypertensive Drugs Sales and Growth Rate (2011-2016)
Figure China Antihypertensive Drugs Revenue and Growth Rate (2011-2016)
Figure China Antihypertensive Drugs Sales Price Trend (2011-2016)
Table China Antihypertensive Drugs Sales by Manufacturers (2011-2016)
Table China Antihypertensive Drugs Market Share by Manufacturers (2011-2016)
Table China Antihypertensive Drugs Sales by Type (2011-2016)
Table China Antihypertensive Drugs Market Share by Type (2011-2016)
Table China Antihypertensive Drugs Sales by Application (2011-2016)
Table China Antihypertensive Drugs Market Share by Application (2011-2016)
Figure Europe Antihypertensive Drugs Sales and Growth Rate (2011-2016)
Figure Europe Antihypertensive Drugs Revenue and Growth Rate (2011-2016)
Figure Europe Antihypertensive Drugs Sales Price Trend (2011-2016)
Table Europe Antihypertensive Drugs Sales by Manufacturers (2011-2016)
Table Europe Antihypertensive Drugs Market Share by Manufacturers (2011-2016)
Table Europe Antihypertensive Drugs Sales by Type (2011-2016)
Table Europe Antihypertensive Drugs Market Share by Type (2011-2016)
Table Europe Antihypertensive Drugs Sales by Application (2011-2016)
Table Europe Antihypertensive Drugs Market Share by Application (2011-2016)
Figure Japan Antihypertensive Drugs Sales and Growth Rate (2011-2016)
Figure Japan Antihypertensive Drugs Revenue and Growth Rate (2011-2016)
Figure Japan Antihypertensive Drugs Sales Price Trend (2011-2016)
Table Japan Antihypertensive Drugs Sales by Manufacturers (2011-2016)
Table Japan Antihypertensive Drugs Market Share by Manufacturers (2011-2016)
Table Japan Antihypertensive Drugs Sales by Type (2011-2016)
Table Japan Antihypertensive Drugs Market Share by Type (2011-2016)
Table Japan Antihypertensive Drugs Sales by Application (2011-2016)
Table Japan Antihypertensive Drugs Market Share by Application (2011-2016)
Table Novartis AG Basic Information List
Table Novartis AG Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis AG Antihypertensive Drugs Global Market Share (2011-2016)
Table Pfizer, Inc. Basic Information List
Table Pfizer, Inc. Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. Antihypertensive Drugs Global Market Share (2011-2016)
Table Johnson & Johnson Ltd. Basic Information List
Table Johnson & Johnson Ltd. Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Johnson & Johnson Ltd. Antihypertensive Drugs Global Market Share (2011-2016)
Table Sanofi S.A. Basic Information List
Table Sanofi S.A. Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi S.A. Antihypertensive Drugs Global Market Share (2011-2016)
Table Lupin Limited Basic Information List
Table Lupin Limited Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Lupin Limited Antihypertensive Drugs Global Market Share (2011-2016)
Table Ranbaxy Laboratories Limited Basic Information List
Table Ranbaxy Laboratories Limited Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Ranbaxy Laboratories Limited Antihypertensive Drugs Global Market Share (2011-2016)
Table Merck & Co., Inc. Basic Information List
Table Merck & Co., Inc. Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck & Co., Inc. Antihypertensive Drugs Global Market Share (2011-2016)
Table Astra Zeneca Plc Basic Information List
Table Astra Zeneca Plc Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Astra Zeneca Plc Antihypertensive Drugs Global Market Share (2011-2016)
Table Daiichi Sankyo Company Limited Basic Information List
Table Daiichi Sankyo Company Limited Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Daiichi Sankyo Company Limited Antihypertensive Drugs Global Market Share (2011-2016)
Table Takeda Pharmaceutical Company Limited Basic Information List
Table Takeda Pharmaceutical Company Limited Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Takeda Pharmaceutical Company Limited Antihypertensive Drugs Global Market Share (2011-2016)
Table Actelion Ltd. Basic Information List
Table Actelion Ltd. Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Actelion Ltd. Antihypertensive Drugs Global Market Share (2011-2016)
Table United Therapeutics Corp Basic Information List
Table United Therapeutics Corp Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure United Therapeutics Corp Antihypertensive Drugs Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antihypertensive Drugs
Figure Manufacturing Process Analysis of Antihypertensive Drugs
Figure Antihypertensive Drugs Industrial Chain Analysis
Table Raw Materials Sources of Antihypertensive Drugs Major Manufacturers in 2015
Table Major Buyers of Antihypertensive Drugs
Table Distributors/Traders List
Figure Global Antihypertensive Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Global Antihypertensive Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Global Antihypertensive Drugs Sales Forecast by Regions (2016-2021)
Table Global Antihypertensive Drugs Sales Forecast by Type (2016-2021)
Table Global Antihypertensive Drugs Sales Forecast by Application (2016-2021)


More Publications